(Originally published at The Daily Sheeple)
The Business Insider just reported that a new company Editas Medicine (sounds like “edit us,” doesn’t it?) just raised $120 million to continue working with a new technology known as CRISPR-Cas9 which enables scientists to tweak defective genes or even swap them out for new ones. They’ve already been repairing defective genes in mice with it.
Considering Bill Gates is largely funding it, however, you can rest assured that if anything good actually comes of this (as in, it’s not just some creepy transhumanist scientific dictatorship science experiment), it won’t benefit the average people like those who are reading this article right now.